国泰疫苗与生物科技ETF联接A(017185)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
397,846.62 |
13,575.46 |
13,325.58 |
8,254.78 |
| 存出保证金 |
7,142.12 |
7,977.68 |
10,516.24 |
7,224.13 |
| 交易性金融资产 |
64,032,763.72 |
8,937,930.95 |
8,817,569.78 |
9,509,448.87 |
| 其中:股票投资 |
- |
- |
- |
- |
| 债券投资 |
201,334.54 |
101,270.58 |
303,950.68 |
506,614.52 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
29,039.57 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
28,550.34 |
14,176.59 |
13,653.54 |
3,821.14 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
68,184,645.07 |
9,556,552.36 |
9,106,214.46 |
9,734,488.51 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
93,345.43 |
- |
- |
| 应付赎回款 |
163,825.57 |
53,322.48 |
41,317.23 |
166,537.45 |
| 应付管理人报酬 |
2,025.69 |
243.69 |
255.38 |
357.83 |
| 应付托管费 |
405.11 |
48.73 |
51.09 |
71.53 |
| 应付销售服务费 |
3,753.43 |
389.98 |
524.14 |
1,011.85 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
3.82 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
12,017.48 |
3,223.67 |
6,080.82 |
6,592.26 |
| 负债合计 |
182,031.10 |
150,573.98 |
48,228.66 |
174,570.92 |
| 所有者权益 |
| 实收基金 |
106,171,338.41 |
15,425,983.21 |
14,468,818.28 |
16,270,291.14 |
| 未分配利润 |
-38,168,724.44 |
-6,020,004.83 |
-5,410,832.48 |
-6,710,373.55 |
| 所有者权益合计 |
68,002,613.97 |
9,405,978.38 |
9,057,985.80 |
9,559,917.59 |
| 负债及所有者权益总计 |
68,184,645.07 |
9,556,552.36 |
9,106,214.46 |
9,734,488.51 |